Loading...
Orthofix Medical Inc.
OFIX•NASDAQ
Healthcare
Medical - Devices
$11.27
$0.03(0.27%)
Orthofix Medical Inc. (OFIX) Financial Performance & Income Statement Overview
Review Orthofix Medical Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
7.08%
↑ 7.08%
Operating Income Growth
39.17%
↑ 39.17%
Net Income Growth
16.78%
↑ 16.78%
Operating Cash Flow Growth
156.37%
↑ 156.37%
Operating Margin
-12.55%
↓ 12.55%
Gross Margin
66.08%
↑ 66.08%
Net Profit Margin
-17.78%
↓ 17.78%
ROE
-28.15%
↓ 28.15%
ROIC
-14.87%
↓ 14.87%
Orthofix Medical Inc. (OFIX) Income Statement & Financial Overview
Review Orthofix Medical Inc.'s (OFIX) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $215.66M | $196.61M | $198.62M | $188.61M |
| Cost of Revenue | $66.82M | $61.55M | $68.19M | $65.59M |
| Gross Profit | $148.84M | $135.05M | $130.43M | $123.02M |
| Gross Profit Ratio | $0.69 | $0.69 | $0.66 | $0.65 |
| R&D Expenses | $18.81M | $17.29M | $18.05M | $19.49M |
| SG&A Expenses | $136.48M | $130.14M | $134.12M | $131.69M |
| Operating Expenses | $155.29M | $153.95M | $152.17M | $151.18M |
| Total Costs & Expenses | $222.10M | $215.50M | $220.36M | $216.78M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $14.92M | $5.21M | $4.94M | $4.56M |
| Depreciation & Amortization | $15.99M | $16.79M | $14.03M | $14.86M |
| EBITDA | $12.54M | -$4.64M | -$13.38M | -$15.75M |
| EBITDA Ratio | $0.06 | -$0.02 | -$0.07 | -$0.08 |
| Operating Income | -$6.45M | -$18.90M | -$21.74M | -$28.17M |
| Operating Income Ratio | -$0.03 | -$0.10 | -$0.11 | -$0.15 |
| Other Income/Expenses (Net) | -$23.27M | -$7.74M | -$7.45M | -$5.83M |
| Income Before Tax | -$29.71M | -$26.64M | -$32.36M | -$35.17M |
| Income Before Tax Ratio | -$0.14 | -$0.14 | -$0.16 | -$0.19 |
| Income Tax Expense | -$564000.00 | $751000.00 | $1.08M | $851000.00 |
| Net Income | -$29.15M | -$27.39M | -$33.44M | -$36.02M |
| Net Income Ratio | -$0.14 | -$0.14 | -$0.17 | -$0.19 |
| EPS | -$0.75 | -$0.71 | -$0.88 | -$0.95 |
| Diluted EPS | -$0.75 | -$0.71 | -$0.88 | -$0.95 |
| Weighted Avg Shares Outstanding | $38.70M | $38.49M | $38.02M | $37.74M |
| Weighted Avg Shares Outstanding (Diluted) | $38.70M | $38.49M | $38.02M | $37.74M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan